Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer
In elderly breast cancer patients with moderate- to high-risk early-stage disease for whom standard chemotherapy is too toxic, the chemotherapy capecitabine, which causes fewer side effects than the standard chemotherapy ...
Dec 12, 2014
0
0